Insider Shareholders with Direct Ownership of Avidity Biosciences, Inc. (RNA)
This section provides a comprehensive overview of the insiders with direct ownership of Avidity Biosciences, Inc. (RNA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Avidity Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,169,396 | 0 | 2,169,396 $71.4 Million | 1 |
Jun 16, 2020
Added 50.0%
|
|
|
Sarah Boyce
President and CEO |
1,181,000 | 848,298 | 337,411 $11.1 Million | 44 |
Jan 21, 2025
Reduced 1.65%
|
|
Teresa Mc Carthy
Chief Human Resources Officer |
261,500 | 139,192 | 104,908 $3.45 Million | 18 |
Jan 21, 2025
Reduced 1.15%
|
|
Michael F Mac Lean
Chief Financial Officer |
464,302 | 364,356 | 104,655 $3.45 Million | 18 |
Jan 21, 2025
Reduced 1.57%
|
|
W. Michael Flanagan
Chief Scientific Officer |
368,000 | 255,543 | 91,975 $3.03 Million | 16 |
Jan 21, 2025
Reduced 1.93%
|
|
Troy Edward Wilson
Director |
0 | 100,000 | 89,618 $2.95 Million | 1 |
Dec 22, 2020
Reduced 52.74%
|
|
Steven George Hughes
Chief Medical Officer |
25,000 | 3,947 | 82,428 $2.71 Million | 2 |
Jan 21, 2025
Reduced 2.41%
|
|
Eric Mosbrooker
Chief Commercial Officer |
25,000 | 0 | 61,120 $2.01 Million | 1 |
Jan 06, 2025
Added 29.03%
|
|
Kathleen P. Gallagher
Chief Program Officer |
25,000 | 9,411 | 50,554 $1.66 Million | 3 |
Jan 22, 2025
Reduced 10.02%
|
|
John B Moriarty
Chief Legal Officer |
50,000 | 0 | 50,000 $1.65 Million | 2 |
Jan 06, 2025
Added 33.33%
|
|
Charles Calderaro Iii
Chief Technical Officer |
40,000 | 0 | 40,000 $1.32 Million | 1 |
Jan 06, 2025
Added 50.0%
|
|
Arthur A Levin
Director |
276,423 | 264,795 | 12,958 $426,706 | 47 |
Jan 21, 2025
Reduced 12.62%
|
|
Tamar Thompson
Director |
30,000 | 30,000 | 0 $0 | 2 |
Oct 07, 2024
Reduced 100.0%
|